patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Re: Pluristem Therapeutics Set to Enter Bone Marrow Disease Market as it is Preparin
Reply New Message
Back To Forum List View
Pluristem Therapeutics Set to Enter Bone Marrow Disease Market as it is Preparin
3
greybeard
Jul 23, 2012 08:57AM
Icon president Re: Pluristem Therapeutics Set to Enter Bone Marrow Disease Market as it is Preparin
2
emit
Jul 23, 2012 04:55PM
Icon president Re: Pluristem Therapeutics Set to Enter Bone Marrow Disease Market as it is Preparin
1
emit
Jul 23, 2012 04:58PM

European regulation on orphan medicinal products: 10 years of ...

www.nature.com/nrd/journal/v10/n5/full/nrd3445.html
You +1'd this publicly. Undo
Apr 29, 2011 – The average time between receiving an orphan designation and marketing authorization was 2.8 years.
So far, my DD, looks like USA FDA is 3 years. yuk,
Hope more terminals and their doctors cry for a Pluristem fix....
e
2 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply